Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Gains from Investment Securities (2016 - 2025)

Bruker (BRKR) has disclosed Gains from Investment Securities for 16 consecutive years, with -$31.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 443.86% year-over-year to -$31.0 million, compared with a TTM value of -$27.9 million through Dec 2025, down 26.24%, and an annual FY2025 reading of -$27.9 million, down 26.24% over the prior year.
  • Gains from Investment Securities was -$31.0 million for Q4 2025 at Bruker, down from $2.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $39.4 million in Q4 2023 and bottomed at -$31.0 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is -$4.0 million, with a median of -$1.8 million recorded in 2022.
  • The sharpest move saw Gains from Investment Securities soared 428.0% in 2023, then tumbled 2545.45% in 2024.
  • Year by year, Gains from Investment Securities stood at $1.4 million in 2021, then tumbled by 2077.64% to -$26.8 million in 2022, then soared by 247.01% to $39.4 million in 2023, then tumbled by 114.47% to -$5.7 million in 2024, then tumbled by 443.86% to -$31.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for BRKR at -$31.0 million in Q4 2025, $2.7 million in Q3 2025, and $1.4 million in Q2 2025.